Annual report pursuant to Section 13 and 15(d)

INVESTMENTS IN UNCONSOLIDATED JOINT VENTURES - Schedule of Equity Method Investment, Summarized Financial Information, Income Statement (Details)

v3.22.4
INVESTMENTS IN UNCONSOLIDATED JOINT VENTURES - Schedule of Equity Method Investment, Summarized Financial Information, Income Statement (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Schedule of Equity Method Investments [Line Items]      
Total revenues $ 355,018 $ 323,390 $ 307,476
Operating and other expenses (77,855) (71,246) (67,592)
Depreciation and amortization (111,518) (110,038) (120,455)
Interest expense (78,040) (65,192) (80,991)
Net income (loss) (34,885) (109,539) (33,598)
Equity Method Investment, Nonconsolidated Investee or Group of Investees      
Schedule of Equity Method Investments [Line Items]      
Total revenues 140,637 173,169 275,246
Operating and other expenses (81,914) (131,709) (224,195)
Depreciation and amortization (25,412) (25,095) (34,587)
Interest expense (29,777) (27,145) (29,420)
Net income (loss) $ 3,534 $ (10,780) $ (12,956)